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R enal ischemia-reperfusion (I/R) injury causes acute renal failure in various clinical settings, including kidney transplantation and cardiopulmonary and aor-tic bypass surgery. Renal I/R injury is associated with high mortality and morbidity (1, 2) . Ischemia typically damages renal tubular epithelial cells and also glomerular cells and is characterized by several hallmark features at the cellular level, including profound intracellular adenosine triphosphate depletion and a fall in tissue oxygen and glucose content with a concomitant rise in intracellular calcium (3, 4) . Although ischemic events alone may lead to necrosis and apoptosis in the kidneys, reperfusion occurs upon restoration of blood flow and is associated with production of reactive oxygen species, inflammatory mediators, and increased apoptosis as well as necrosis (5, 6) . It has been shown that renal I/R injury can be ameliorated by inhibiting molecules involved in apoptosis, necrosis, or inflammation, suggesting that multiple injury and death mechanisms may be involved in renal I/R injury (7) . Among these, the coexistence of apoptosis and necrosis in renal tissues is a characteris-tic feature of renal I/R injury. Both types of cell death have been implicated significantly in the pathogenesis of acute renal failure, which is marked by a loss of tubular epithelial cells and subsequent renal dysfunction (8, 9) .
Furthermore, there is growing evidence that additional mechanisms that contribute to the ongoing pathogenesis of I/R injury-induced acute renal failure. For instance, renal vascular endothelial injury and dysfunction, due to increases in renal vascular resistance and persistent reductions in renal blood flow, exacerbates hypoxia and plays an important part in extending renal tubular epithelial injury and subsequent cell death (10) .
Milk fat globule-epidermal growth factor-factor VIII (MFG-E8) is a membraneassociated glycoprotein originally found in milk and mammary epithelial cells (11) . It has been shown that MFG-E8 is expressed in various cells, including macrophages, dendritic cells, and in several other epithelial cells, such as photorecep-tor cells, retinal pigment epithelium cells, lamina propria epithelial cells of colonic mucosa, endometrial glandular, and surface-luminal epithelial cells (12) (13) (14) (15) (16) (17) . Previous investigators have reported that MFG-E8 participates in multiple physiologic processes associated with tissue remodeling (18) . Among these, Hanayama et al (15, 19) have found that MFG-E8 negatively regulates inflammation and autoimmunity by facilitating the clearance of apoptotic cells. Recently, we have shown that MFG-E8 has a similar impact on outcome in acute inflammatory conditions, including sepsis and gut I/R injury. Exogenous administration of MFG-E8 ameliorated inflammatory responses and improved survival through the enhancement of phagocytosis of apoptotic cells (20 -26) .
Therefore, we hypothesized from these evidences that MFG-E8 attenuates tissue damage after renal I/R injury. In this report, we investigated the effects of renal I/R injury on MFG-E8 expression and whether administration of MFG-E8 beneficially affects associated inflammatory responses, tubular cell death, and capillary dysfunction. Some of the results of this study were previously reported in the form of an abstract (27) .
MATERIALS AND METHODS
Animal Model of Renal I/R Injury. Male C57BL/6J mice (20 -25 g; Taconic, Albany, NY) were randomly assigned to different groups (n ϭ 11/group). Mice were anesthetized with isoflurane inhalation. Using a midline abdominal incision, renal I/R injury was induced by bilateral renal pedicle clamping with microvascular clamps for 45 min. Then the clamp was removed, and the reflow (reperfusion) was visually verified. At the beginning of reperfusion, mice were resuscitated with 0.5 mL saline intraperitoneally and were treated with recombinant murine MFG-E8 (rmMFG-E8; R&D Systems, Minneapolis, MN) (0.4 g/20 g body weight in 0.5 mL normal saline intraperitoneally) or normal saline (Vehicle). Control animals underwent the same surgical procedure, except for the clamping of the renal pedicle (Sham). At 1.5 and 20 hrs after reperfusion, animals were anesthetized, and plasma and tissue samples were harvested and stored at Ϫ80°C until experiments. All experiments were performed in accordance with the guidelines for the use of experimental animals by the National Institutes of Health (Bethesda, MD) and were approved by the Institutional Animal Care and Use Committee of The Feinstein Institute for Medical Research (Manhasset, NY).
Determination of Organ Injury Variables. Plasma levels of blood urea nitrogen, creatinine, and alanine aminotransferase were determined at 20 hrs after reperfusion by using commercial assay kits according to the manufacturer's instructions (Pointe Scientific, Lincoln Park, MI).
Water Content Determination and Histologic Examination. Kidney and liver edema was estimated at 20 hrs after reperfusion by comparing wet-to-dry ratios. Tissues were dried in a 70°C oven for 72 hrs. Tissue water content was calculated as percent H 2 O ϭ (1 Ϫ dry weight/wet weight) ϫ 100%. Morphologic alterations in the kidneys were examined at 20 hrs after reperfusion by light microscopy. The tissue was fixed in 10% formalin and later embedded in paraffin. The tissue paraffin sections (4-m thick) were stained with hematoxylin and eosin. Histologic changes in the cortex and in the outer stripe of the outer medulla were assessed by quantitative measurements of tissue damage in a blinded fashion. Tubular damage was defined as tubular epithelial swelling, loss of brush border, vacuolization, necrotic tubules, cast formation, and desquamation. The degree of kidney damage was estimated by the following criteria: 0, normal; 1, area of damage Ͻ25% of tubules; 2, damage involving 25%-50% of tubules; 3, damage involving 50%-75% of tubules; and 4, 75%-100% of the area being affected (28) .
Myeloperoxidase (MPO) Immunohistochemistry and Measurement of MPO Activity. Kidney samples were taken at 20 hrs after reperfusion and the paraffin-embedded kidney sections were blocked and stained with rabbit anti-MPO antibody (Abcam, Cambridge, MA). After washing, the sections were reacted in biotinylated anti-rabbit IgG. Vectastain ABC reagent and DAB kit (Vector, Burlingame, CA) were used to reveal the immunohistochemical reaction. For the negative control, the primary antibody was substituted with normal rabbit IgG. Neutrophil accumulation within the kidneys was also estimated using the MPO activity assay, which uses the peroxidase catalyzed reaction, as we described previously (29) .
Western Blotting. Tissue protein was fractionated on a Bis-Tris gel and transferred to a nitrocellulose membrane. The membranes were blocked by incubation in TBS with 0.1% Tween 20 containing 5% bovine serum albumin or milk and incubated with primary anti-MFG-E8, poly(ADP-ribose) polymerase, and vascular endothelial growth factor (VEGF) antibodies (Santa Cruz Biotechnology, Santa Cruz, CA). After washing, the blots were incubated with horseradish peroxidase-labeled secondary antibody and washed. Bands were detected using a chemiluminescent peroxidase substrate (ECL Plus, Amersham, Little Chalfont, Buckinghamshire, UK).
Quantitative Real-Time Polymerase Chain Reaction. Total RNA was extracted from tissue samples after 20 hrs reperfusion using TRIzol reagent (Invitrogen, Carlsbad, CA). cDNA was synthesized from 2 g of total RNA using Oligo (dT) [12] [13] [14] [15] [16] [17] [18] primer (Invitrogen) and murine leukemia virus reverse transcriptase (Applied Biosystems, Foster City, CA). The expressions of target mRNAs were detected by quantitative real-time polymerase chain reaction (7300 Real Time PCR System, Applied Biosystems) with SYBR Green as detection dye. Primer sequences are described in Table  1 . Relative expression of each mRNA was calculated using ⌬⌬ Ct threshold method.
Terminal Deoxynucleotide Transferase dUTP Nick-End Labeling (TUNEL) Assay. The presence of apoptotic renal tubular cells in the kidney sections were assessed after 1.5-hr reperfusion using a TUNEL staining kit (Roche Diagnostics, Indianapolis, IN) un- Forward: CGTGAAAAGATGACCCAGATCA Reverse: TGGTACGACCAGAGGCATACAG der a fluorescence microscope, as described previously (26) . Survival Study. To determine the role of MFG-E8 for survival benefit after renal I/R injury, C57BL6/J wild-type (WT) mice with or without rmMFG-E8 treatment (a single dose, 0.4 g/20 g, intraperitoneal administration of rmMFG-E8 at the beginning of reperfusion), and male C57BL6/J MFG-E8 knockout mice (a generous gift from Dr. Shigekazu Nagata, Kyoto University, Kyoto, Japan) were subjected to renal I/R injury and observed for 60 hrs after the operation.
Statistical Analysis. Data are expressed as mean Ϯ SEM and compared by one-way analysis of variance using Student Newman-Keuls test. Student's t test was used for two-group analysis. The survival study was analyzed using the Kaplan-Meier method and compared by log-rank test. Differences in values were considered significant at p Ͻ .05.
RESULTS

Suppression of MFG-E8 in Various Organs after Renal I/R Injury.
To investigate whether MFG-E8 levels are altered after renal I/R injury, we measured its messenger RNA (mRNA) and protein levels 20 hrs after reperfusion. MFG-E8 is reported to be mainly produced in the spleen (19, 30) . Therefore, we assessed the levels in the spleen, kidneys, and liver. Splenic MFG-E8 mRNA and protein levels decreased by an average 36% and 41%, respectively, after renal I/R injury (p Ͻ .05, Fig. 1, A and B) . Similarly, both MFG-E8 mRNA and protein levels in the kidneys decreased by 45% after renal I/R injury (p Ͻ .05, Fig. 1, C and D) . In the liver, MFG-E8 mRNA and protein levels decreased by 49% and 26%, respectively, although the decrease of protein levels was not statistically significant (p Ͻ .05 and p ϭ .18, respectively, Fig. 1 , E and F).
Administration of rmMFG-E8 Attenuates Renal and Liver Dysfunction after Renal I/R Injury. In the measurement of renal excretory function, mice that were subjected to renal I/R injury had renal dysfunction at 20 hrs after reperfusion, as expected by significant increase in plasma blood urea nitrogen and creatinine levels compared with sham-operated mice. In contrast, treatment with rmMFG-E8 largely attenuated I/R injury-induced renal dysfunction (p Ͻ .05, Fig. 2, A and B) . Furthermore, treatment with rmMFG-E8 significantly suppressed the I/R injuryinduced elevation of alanine aminotransferase, which indicates the injury of the distant organ that is induced by this model (p Ͻ .05, Fig. 2C ).
Administration of rmMFG-E8 Attenuates Renal Tubular Injury after Renal I/R
Injury. Figure 3 shows the renal histology in the cortex and outer stripe of outer medulla area 20 hrs after reperfusion. Renal I/R injury induced remarkable tubular damage, including loss of brush border, necrotic tubules, and cast formation, compared with sham-operated mice, which showed the normal renal structures ( Fig. 3, A, B , D, and E). Similar to previous reports demonstrating that tu-bular epithelial cells in the medulla are more susceptible to I/R injury than those in the cortex, our results showed that the tubular damage in the outer stripe of outer medulla was more severe compared with that in cortex (8, 31) . In contrast, this tubular damage was remarkably attenuated in all rmMFG-E8-treated mice (Fig. 3, C and F) . Quantification of the tubular damage in the cortex and outer stripe of outer medulla area showed a significantly lower tubular injury score in Administration of rmMFG-E8 Attenuates Renal and Liver Edema after Renal I/R Injury. As shown in Figure 4 , mice subjected to renal I/R had a significant increase of water content in the kidneys (Fig. 4A ) and liver (Fig. 4B ) at 20 hrs after reperfusion as compared with shamoperated mice (p Ͻ .05). When renal I/R injury mice were treated with rmMFG-E8, both kidney and liver water contents were reduced and there were no statistical differences between sham-operated and rmMFG-E8-treated mice.
Administration of rmMFG-E8 Suppresses Inflammatory Responses after Renal I/R Injury. Proinflammatory cytokines and chemokines are major contributors to the organ injury after renal I/R injury (32) . We investigated whether in-terleukin-1␤ (IL-1␤), IL-6, and macrophage inflammatory protein-2 (MIP-2) mRNA expressions in the kidneys were affected by the treatment with rmMFG-E8. As expected, kidney levels of the cytokines and chemokine increased significantly after renal I/R injury (IL-1␤ by 19.9-fold, IL-6 by 3.3-fold, and MIP-2 by 12.3-fold). Treatment with rmMFG-E8 significantly reduced the proinflammatory response by 51%, 40%, and 37%, respectively (p Ͻ .05, Fig. 5A-C) .
Administration of rmMFG-E8 Suppresses Neutrophil Infiltration after Renal I/R Injury.
To determine the alterations in neutrophil infiltration, immunohistochemical staining of kidney sections for MPO was performed. Consistent with the increased expression of MIP-2, a potent chemoattractant for neutrophils, MPO immunostaining increased 20 hrs after reperfusion in vehicle-treated mice compared with sham-operated mice (Fig. 6, A  and B) . Treatment with rmMFG-E8 after renal I/R injury reduced the MPO immunostaining ( Fig. 6C ). Likewise, MPO activity in the kidneys increased by 4.3-fold after renal I/R injury. Treatment with rmMFG-E8 markedly reduced the kidney MPO activity similar to sham levels (p Ͻ .05, Fig. 6D ).
Administration of rmMFG-E8 Suppresses Apoptosis after Renal I/R Injury. As a measure of tubular cell apoptosis, TUNEL staining of kidney sections was performed. At 20 hrs after reperfusion, the majority of positive staining was derived from the fragmented nuclei in vehicletreated mice (data not shown). Considering that this method detects not only apoptotic cells but extensive DNA fragmentation that is occurring in certain forms of necrotic cells (33, 34) , fragmented positive staining could be due to tubular necrosis. Therefore we chose an earlier time point than 20 hrs. At 1.5 hrs after reperfusion, apoptotic tubular cells showed positive staining of whole nuclei in both vehicle-and rmMFG-E8-treated mice. However, treatment with rmMFG-E8 suppressed the number of apoptotic cells in the kidneys after renal I/R injury ( Fig. 7A-C) . We also employed poly-(ADP-ribose) polymerase Western blot as a marker of apoptosis. Mice subjected to renal I/R had a significant increase of cleaved poly(ADP-ribose) polymerase expression in the kidneys after 20 hrs reperfusion. Treatment of rmMFG-E8 decreased kidney cleaved poly(ADP-ribose) polymerase levels significantly to levels similar to those in sham animals (Fig. 7D ). 
Administration of rmMFG-E8 Improves Capillary Function after Renal I/R
Injury. As a measure of capillary function, VEGF, and endothelin-1 (ET-1) expressions in the kidneys after 20 hrs after reperfusion were assessed. VEGF mRNA levels were decreased significantly by 61% and protein levels by 32% after renal I/R injury. Treatment with rmMFG-E8 significantly increased VEGF mRNA and protein levels in renal I/R injury mice (p Ͻ .05, Fig. 8, A and B) . Furthermore, ET-1 mRNA levels were significantly increased by 55% after renal I/R injury, and treatment with rmMFG-E8 significantly reduced them to levels similar to shamoperated mice (p Ͻ .05, Fig. 8C ).
MFG-E8 Has Survival Benefit after Renal I/R Injury. The above results suggest that rmMFG-E8 treatment is beneficial in renal I/R-mediated organ injury. We therefore conducted a survival study to prove the long-term benefit of MFG-E8 using MFG-E8 knockout (MFG-E8 Ϫ/Ϫ group) and WT mice with (rmMFG-E8 group) or without (Vehicle group) rmMFG-E8 treatment. Figure 9 shows the survival curves in each groups. The survival rate at 60 hrs after renal I/R injury in the MFG-E8 Ϫ/Ϫ group was significantly lower than that in the Vehicle group (11.1% vs. 43.8%; p Ͻ .05). The rmMFG-E8 group showed a significant improvement of the survival rate to 73.3% compared with that in the Vehicle group (p Ͻ .05).
DISCUSSION
In this study, we show that MFG-E8 expression was decreased and treatment with MFG-E8 attenuated renal tissue damage and renal excretory dysfunction in the mice after renal I/R injury. These beneficial effects of MFG-E8 were associated with suppression of inflammatory responses, tubular cell death induced by apoptosis and necrosis, and improvement of capillary function. To our knowledge, this is the first study to demonstrate effects of MFG-E8 against I/R injury in the kidneys.
MFG-E8 participates in various physiologic functions associated with tissue remodeling and maintenance of homeostasis (18) . Hanayama et al (15) have shown that MFG-E8 is one of the bridging molecules between apoptotic cells and phagocytes by binding to phosphatidylserine exposed on apoptotic cells and to ␣ v ␤ 3 / ␣ v ␤ 5 integrins on phagocytes. Additionally, MFG-E8-deficient mice showed var-ious characteristics of inflammation and autoimmunity, and suffered from glomerulonephritis that are specifically due to defects in apoptotic cell engulfment by phagocytes (19) . This may raise the possibility that the kidney is one of the sensitive organs associated with the abnormality of MFG-E8 production. In this report, we demonstrated that MFG-E8 productions in various tissues were decreased after renal I/R injury. We have previously shown that cecal ligation and puncture-induced sepsis and gut I/R injury suppressed MFG-E8 production in vital organs. Stimulation with lipopolysaccharide, which plays a pivotal role in the pathogenesis of cecal ligation and puncture sepsis, in vitro and in vivo also suppressed MFG-E8 production (20, 21, 23, 24, 35) . Given the fact that renal I/R injury has less chance in exposure to lipopolysaccharide, other candidate pathways besides lipopolysaccharide should exist for the downregulation of MFG-E8 after renal I/R injury. Furthermore, which cell type is affected by the decline of MFG-E8 under renal I/R injury condi- tions is currently not known and is subject to further investigation.
As an attempt to reveal a mechanism of renoprotection by MFG-E8 treatment, we investigated apoptotic cell death because several studies have been reported in which MFG-E8 plays an important role at the interface between phagocytosis of apoptotic cells and inflammation in chronic and acute inflammatory diseases (19, 24, 25) . Induction of apoptosis is one of the major causes of tissue damage after renal I/R injury. Inhibition of certain elements of the apoptotic pathway seemed to ameliorate renal I/R injury (36, 37) . Recently, it has been shown that not only necrotic cells but also apoptotic cells that were not engulfed appropriately by phagocytes, a process termed "secondary necrosis," release potentially cytotoxic and antigenic intracellular contents that can promote an inflammatory response (38, 39) . It is also reported that increases in apoptosis after renal I/R injury were directly associated with increased renal inflammation and following further tissue damage (40, 41) . Our results showed that treatment with MFG-E8 reduced the number of apoptotic cells and suppressed local inflammation after renal I/R injury. Although we have no direct data showing the impairment of phagocytosis, it is suggested from previous studies (15, 19, 24, 25, 42) that decreased MFG-E8 expression in our model is associated with impaired phagocytosis of apoptotic cells and that the beneficial effect of MFG-E8 treatment is partially due to its recovery.
The histologic amelioration of overall tubular disruption in rmMFG-E8-treated mice was a highly significant observation (Fig. 3) . Apparently, in addition to apoptosis, tubular necrosis was suppressed in these animals as well. Considering our result, despite the increased amount of necrotic tubular cells in histology, apoptosis was seen in a small minority of tubular cells as evidenced by the TUNEL stains in our renal I/R injured mice. Previous reports have shown that necrosis of proximal tubules is more predominant than apoptosis in renal I/R injury (43, 44) . Based on these observations, we speculate that necrotic tubular cell death and subsequent hyperinflammatory responses should contribute to renal injury in this model and that the beneficial effect of MFG-E8 treatment is attributed more to a decrease of necrosis instead of apoptosis.
Increasing number of evidences have reported that I/R injury induces renal vascular damage, which may prolong the hypoperfused state of the kidney and exacerbate renal injury following I/R (10, 45) . Furthermore, recent studies have focused on rapid changes in the blood flow as the initiation or maintenance of injury in the settings of I/R injury. Yamamoto et al (46) reported that in vivo renal perfusion in peritubular vessels was decreased within minutes of reperfusion. It is well known that the reduced blood flow and hypoxic conditions that occur in renal I/R injury lead to deprivation of vital nutrients and loss of adenosine triphosphate in the vascular and tubular cells causing necrotic cell death (7) .
Recent findings indicate that VEGF is not only a potent vascular permeability and angiogenic regulator, but also regulates various capillary functions, including endothelial cell proliferation and vasodilatation, by preventing endothelial apoptosis and exertion of anti-inflammatory effects (47, 48) . So far, the alteration of VEGF expressions after renal I/R injury is controversial (49, 50) . However, consistent with our result, Basile et al (51) reported that VEGF expression was repressed in early phases of renal I/R injury. The loss of VEGF expression was due to the reduction of its content in proximal tubules and to increased production of molecules that inhibit VEGF activity. The mechanism involving the recovery of VEGF expression by MFG-E8 treatment is unknown. However, a previous report has suggested a direct interaction between VEGF and MFG-E8. Silvestre et al (52) reported that MFG-E8 is required for VEGF-dependent blood vessel growth and increase in blood flow, not only under physiologic but also ischemic condition. Furthermore, VEGF induces an increase of MFG-E8 production in endothelial cells.
One of the hallmark features in renal vasculature after I/R injury is prolonged vasoconstriction, so that functional recovery may be prevented or delayed (53) . ET-1 is a potent vasoconstrictor produced by endothelial cells, which play a crucial role in the dysregulation of tissue microvascular perfusion (54) . ET-1 has been implicated in the pathogenesis of renal I/R injury, in which ET-1 expression is elevated in postischemic kidneys (55, 56) . Modulating enhanced ET-1 expressions by 17␤-estradiol is reported to exhibit protective effects after renal I/R injury. This suppression of ET-1 is suggested to be derived from the regulation of nuclear factor-B activation at a transcriptional level of the ET-1 gene (57, 58) . It is likely that MFG-E8 can suppress the I/R injuryinduced ET-1 overexpression through its regulatory effect of nuclear factor-B activation (12) . Furthermore, a recent report (59) has shown that platelet membrane phosphatidylserine is essential for hemostasis and thrombosis, and that MFG-E8 has an anticoagulant property through its blockade of phosphatidylserine exposure on platelets. Taken together, our results suggest that MFG-E8 treatment improves the deteriorated capillary functions after renal I/R injury through various pathways, including VEGFdependent vascular protection, inhibition of vasoconstriction by ET-1, and suppression of thrombosis. Interestingly, we found a significant increase of MFG-E8 expression in the kidney after rmMFG-E8 treatment compared to the Vehicle group (data not shown). Although the detailed mechanism of this restoration is unclear, our histology data have demonstrated the maintenance of normal renal structures by rmMFG-E8 treatment. Therefore, it implies that the kidney epithelial cells produce considerable amounts of MFG-E8, which were lost/damaged due to I/R injury resulting in the decreased levels of MFG-E8; however, the treatment of rmMFG-E8 maintained the normal kidney structures and thereby plays a role in the restoration of endogenous levels of MFG-E8.
In summary, renal I/R injury suppressed MFG-E8 levels and induced considerable organ injury, as characterized by renal dysfunction, increased inflammatory responses, induction of apoptosis and necrosis, and decreased capillary functions in the kidneys. The administration of MFG-E8 ameliorated kidney injury and improved survival. Thus, MFG-E8 can be developed as novel treatment for renal I/R injury. This protective effect appears to be mediated through the enhancement of apoptotic cell clearance and improvement of capillary functions in the kidneys.
